BASE BPA # HHSN261201700002B (POP: 8/1/17 - 7/31/20) master agreement terms and conditions apply. Support services (scientist 21) for pediatric oncology branch, CCR, NCI - BASE period: 8/12/19 -…

Ended Awarded Last action

Contract number
75N91019F00151
Awardee
Awarding agency
Obligated
$123,414

Award facts

Contract value 47% obligated
  • $123,414.00 Current, with exercised options
  • $261,510.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Time and Materials
Place of performance
Red Bank, NJ, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · To DE-obligate funds from FY2019 expiring lines in accordance with NIH oalm communication -$16,804
Original award $140,218

About this award

The National Cancer Institute awarded a time-and-materials Blanket Purchase Agreement (BPA) call valued at $261.5K to Astrix Technology LLC, a scientific staffing solutions provider headquartered in Red Bank, New Jersey. Issued on August 12, 2019, this contract supports the Pediatric Oncology Branch within NCI's Center for Cancer Research, with a base performance period running through August 11, 2020. The award was made under the master agreement framework of BPA HHSN261201700002B (original performance period August 1, 2017 through July 31, 2020) and falls under the Scientific Equipment and Services GSA Schedule (FSS-66). No set-aside designation was applied to this procurement, allowing Astrix Technology to compete on an unrestricted basis.

Under this contract, Astrix Technology provides specialized scientific support services and staffing to advance NCI's research mission. The work was performed at the contractor's location in Red Bank, New Jersey, delivering personnel with expertise in oncology research support functions. This award reflects NCI's broader reliance on specialized contractors to augment its internal scientific workforce and aligns with Astrix Technology's established role as a key provider of scientific, clinical, and administrative staffing solutions across multiple NIH institutes, where the company maintains a substantial $20 million BPA through May 31, 2025.

Description

BASE BPA # HHSN261201700002B (POP: 8/1/17 - 7/31/20) master agreement terms and conditions apply. Support services (scientist 21) for pediatric oncology branch, CCR, NCI - BASE period: 8/12/19 - 8/11/20 (SEVERABLE) time-and-materials period of performance (BASE): 8/12/2019 - 8/11/2020

Quick answers

Who was awarded contract 75N91019F00151?

75N91019F00151 was awarded to Astrix Technology LLC by National Cancer Institute (National Institutes of Health) on August 12, 2019.

How much is contract 75N91019F00151 worth?

The government has obligated $123,414 on 75N91019F00151. Its potential value, with all options, is $261,510.

Is contract 75N91019F00151 an order under another contract?

Yes. 75N91019F00151 is a BPA call under GS07F147DA-HHSN261201700002B, a blanket purchase agreement, on Scientific Equipment and Services (FSS-66).

Was contract 75N91019F00151 competed?

The extent of competition for 75N91019F00151 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award